王樣活動開發整合行銷股份有限公司
Update：2024/12/24
Industries
Main Industry
Sports
Main Product/Service
Early Diagnosis Is Crucial for Pancreatic Cancer
40% of Pancreatic Cancer < 2 cm Are Not Detect on CT
40% of Pancreatic Cancer < 2 cm Are Not Detect on CT
Founded Year
2016
Unified Business No.
46226109
Status
Active
Number of Employees
4
Total Paid-in
Capital
2,100,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PANCREASaver is the first computer-aided detection/diagnosis tool for pancreatic cancer developed by Dr. Wei-Chih Liao, Professor of Medicine of National Taiwan University College of Medicine, and Dr. Weichung Wang, Professor at the Institute of Applied Mathematical Sciences at the National Taiwan University.
In collaboration with National Taiwan University Hospital and other hospitals around the world, PanCAD.ai integrates machine learning, radiomics, and deep learning techniques with clinical data and clinical knowledge on medical imaging to identify medical conditions in clinical workflows.
In collaboration with National Taiwan University Hospital and other hospitals around the world, PanCAD.ai integrates machine learning, radiomics, and deep learning techniques with clinical data and clinical knowledge on medical imaging to identify medical conditions in clinical workflows.
